ascopubs.org

Changes in lymphocyte/monocyte ratio, prognostic marker to predict overall survival in patients with advanced cancer treated with immune checkpoint inhibitor.

Plasma next-generation sequencing (NGS) in advanced non-small cell lung cancer (aNSCLC) patients (pts) treated with immune checkpoint inhibitors (ICIs): Impact of STK11 and TP53 mutations on outcome.
Healio

Inflammation marker may predict 30-day complications of acute MI

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Platelet-to-lymphocyte ratio was tied to 30-day major ...
ascopubs.org

Role of neutrophil-to-lymphocyte, platelet-to-lymphocyte and myelocite-to-lymphocyte ratio as prognostic markers for immunotherapy response in patients with advanced solid ...

Tracking of tumor-derived exosomal PD-L1 for cancer diagnosis and surveilance of immunotherapy response by dual-aptamer-encoded nanocatalyst assembly. This is an ASCO Meeting Abstract from the 2022 ...
The Conversation

Parkinson’s disease: blood changes may occur years before diagnosis

Patients had fewer lymphocytes in their blood. Alexander Raths/ Shutterstock Although Parkinson’s disease affects around 1%-2% of people over the age of 65, there is currently no cure. And by the time ...